The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hi all, I’ve just dipped into RR for the first time. My research indicates that Tucan is going to reignite the growth engine and transform the business. The deal with Airbus for Turkish airlines with RR to be the engine supplier for 70 A350 planes is a great first step. Curious to know what others are thinking around where RR will be in 6-12 months.
I for one am super glad to be invested here. I believe strongly that Kodal will flourish and is a great investment stock for anyone's ISA. I foresee short term upward price movement to 0.5 - 0.6 and once new breaks on the JV or otherwise this will rocket. That can't be too long now.
Good luck to all long term investors and new.
The last RNS was pretty clear. News imminent anytime now. Patience is key - long term holders know.
"In addition to our gold activity, we continue to focus on our Mining Licence Application in Mali, which is progressing as expected, and we welcome the confirmation of Monsieur Lamine Seydou Traore as the Minister of Mines, Energy and Water for Mali. Kodal has continued to work closely with the Mali government to progress the Mining Licence Application, and as previously announced, has both received the request for and paid the Mining Licence Application fee.
In addition to our Mining Licence Application, we note the recent news of the proposed development partnership between our close neighbours at the Goulamina Lithium Project in the Bougouni region of Mali, and Chinese lithium manufacturer, Ganfeng. This joint venture is a very positive indication of support for the Mali lithium sector and further indicates the strength of the lithium sector overall. Kodal is well placed with its Bougouni Lithium Project moving closer to full permitting and the support of our major shareholder and off-take partner, Suay Chin International Pte, as well as other parties who continue to review and assess the development of our primary project.
"I will be in Mali and CĂ´te d'Ivoire throughout the week of 21 June 2021 to undertake a series of Government meetings in the countries and to review the recent exploration programmes. I look forward to providing updates when possible."
Earnings results next week - what can we expect?
Thanks for sharing the link. Very exciting times for KOD - with news imminent on multiple fronts and firefinch receiving an offer from Ganfeng of $130m for half of their Goulamina project right next door, bodes well for all short and long term holders. Further to this Ganfeng may build a Lithium refinery in Mali which will be amazing news for KOD.
https://www.reuters.com/article/us-ganfeng-lithium-mali-mine-idUSKCN2DQ108
(Reuters) -Ganfeng Lithium Co, one of the world’s biggest lithium producers, said on Monday it would pay $130 million for a stake in the Goulamina hard-rock mine in Mali and take at least half of its first-phase output.
The purchase marks the Chinese firm’s first investment in lithium mining in Africa as it seeks to expand production for the commodity used in electric-vehicle batteries.
Ganfeng, which has projects in China, Mexico, Australia, Argentina and Ireland, said in a filing it would take a 50% stake of a special purpose vehicle set up by Goulamina’s current licence holder, Australia-listed Firefinch Ltd, that will fully own operating company Lithium du Mali SA.
GLA
Next news may be completion of IP filing for new CBR platforms (Cell based approach to combat viral infections and cancers.) Vlad had stated in his last video update that they had seen positive results already for treating cancers.
A reminder that Hemo is converting from a small company to a fully functional Clinical trials company and will focus on development of its 2 core products.
The assets are evaluated much higher with completion of proof of concept - up to 100 times the cost of selling the company.
HEMO has more than one product candidate - if more than one candidate passes clinical trials then Vlad may consider partnering with a Global co to support to stage 3 and consider a possible sale.
GLA - buy
i think your right - i checked through my notes from his last presentation which I am reposting below. I wonder if he may change his opinion now that Mint have gone?
Vlad confirmed he is working to return the highest ROI to investors.
Company is converting from a small company to a fully functional Clinical trials company.
HEMO is not for sale - will focus on development of its 2 core products.
The assets are evaluated much higher with completion of proof of concept - up to 100 times the cost of selling the company.
HEMO has more than one product candidate - if more than one candidate passes clinical trials then Vlad may consider partnering with a Global co to support to stage 3 and consider a possible sale.
CBX is reaching out to a global market worth $3.5bn, and 70% of users are over 35 years old. The macro trend is for wellness and self-care, with the hope for some being that Cannabinoid products will likely prove to be the king of wellness ingredients. Indeed, Cellular’s skin products are undergoing product testing and will be approved and are set to be released in the third quarter of 2021. The focus is set to be on Skin, Orthopedic Movement, and Petcare.
Source https://zakmir.com/cbx-can-cellular-deliver-the-goods-for-a-first-day-ten-bagger/
GLA - #buymorecbx